Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Clinical trial NCT04961541 · COMPLETED

Trial details

NCT number: NCT04961541
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

SARS-CoV Infection Covid19

Start date: 2021-09-08
Primary completion: 2021-12-22
Enrollment: 637

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.